Evidently, a Palo Alto, CA-based provider of an AI platform for healthcare workflows, raised $15M in Series A funding.
The round was led by DN Capital with participation from FRAMEWORK, Clear Ventures, and Fellows Fund. As part of the investment, Gulsah Wilke, Partner at DN Capital, will join Evidently’s board of directors.
The company intends to use the funds to meet the demand for its product and expand into population health and clinical research analytics.
Led by CEO Feng Niu, and Chief Product Officer Kalie Dove-Maguire, MD, Evidently develops a cognitive AI platform that enables healthcare providers to access and utilize clinical data effectively. It acts as an AI resident, intelligently synthesizing information from disparate sources including external health records and faxes, and delivers concise, actionable summaries alongside real-time decision support. The company empowers clinicians to deliver care while reducing burnout and driving institutional success.
